101 filings
Page 4 of 6
8-K
sfgszn
4 Sep 20
Departure of Directors or Certain Officers
5:23pm
8-K
fygsj
12 Aug 20
Guardion Health Sciences Reports Results of Operations
4:35pm
8-K
oywfm7c3ewkq9h
23 Jul 20
Guardion Health Sciences Adds Experienced
4:05pm
8-K
rn4ln
16 Jun 20
Guardion Health Sciences Names Dr. David Evans as Interim President and Interim Chief Executive Officer
4:15pm
8-K
7bhw9e 86tp0x92ogih
14 May 20
Guardion Health Sciences Reports First Quarter 2020 Financial Results and Provides Corporate Update
7:10am
8-K
ljifp1ik zerp363s
21 Apr 20
Regulation FD Disclosure
4:57pm
8-K
4skf3
1 Apr 20
Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula
5:04pm
8-K
bos1p4feh7
30 Mar 20
Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview
9:10am
8-K
0m6y kjpk4rtjdii
20 Mar 20
Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
12:00am
8-K
6vm72y6hmoipp1tioy5
6 Mar 20
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
4:05pm
8-K
vbnb8wn6l9un6
30 Dec 19
Departure of Directors or Certain Officers
4:44pm
8-K
8u58cju
10 Dec 19
Amendments to Articles of Incorporation or Bylaws
4:23pm
8-K
e4bh9vi5jkvzh18vzi
31 Oct 19
Guardion Health Sciences Announces Pricing of $8.2 Million Underwritten Public Offering
4:05pm
8-K
4oanrvli0o28kow 3jy
22 Oct 19
Amendments to Articles of Incorporation or Bylaws
4:21pm
8-K
3nnhs
26 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
veei2b 7q9o2y7
24 Sep 19
Entry into a Material Definitive Agreement
4:30pm
8-K
5cj avgyncm
19 Aug 19
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering
4:05pm
8-K
c2xpp
12 Aug 19
Results of Operations and Financial Condition
4:30pm
8-K
da10 n60s9bh9wb5hc8
15 Jul 19
Other Events
5:25pm
8-K
wm6d8zhx
9 Apr 19
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering
4:38pm